BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17/09/2009

FDA Announces Availability of Guidance for Industry: Considerations for Allogeneic Pancreatic Islet Cell Products

The FDA has released a guidance document providing recommendations for manufacturers and investigators involved in clinical trials for allogeneic pancreatic islet cell products to treat type 1 diabetes, finalizing a draft from 2008.

Source: Federal Register — Food and Drug AdministrationOpen original release →